This inventor holds 1 USPTO granted patent. Top assignees: Beth Israel Deaconess Medical Center, Inc., Dana-Farber-Cancer Institute Inc., The General Hospital Corporation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2012
Title: Innovations of Samuel B. Wilson
Introduction
Samuel B. Wilson is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of immunology, particularly in the development of monoclonal and polyclonal antibodies. His work has implications for both diagnostic and therapeutic applications.
Latest Patents
Samuel B. Wilson holds 1 patent for his invention titled "Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations." This invention provides compounds and methods for the ex vivo or in vivo expansion of NK T cells, CD1d-reactive T cells, and JαQT cells, along with the modulation of their activities.
Career Highlights
Throughout his career, Wilson has been associated with prestigious institutions such as Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute. His work at these organizations has allowed him to advance research in the field of cancer and immunotherapy.
Collaborations
Some of his notable coworkers include Steven Balk and Mark A. Exley. Their collaborative efforts have contributed to the advancement of research in immunology and cancer treatment.
Conclusion
Samuel B. Wilson's innovative work in the field of immunology has led to significant advancements in the understanding and treatment of various diseases. His contributions continue to impact the scientific community and improve therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile